HIV/AIDS community involvement

An estimated 65,040 Canadians were living with HIV at the end of 2016.1 GSK has a proud history of contributing to the fight against HIV/AIDS through the research and development of medicines that treat the disease, but recognizes that additional initiatives are needed to intensify and accelerate the response to HIV/AIDS.

Established by GSK and Pfizer in 2009 and joined by Shionogi in 2012, ViiV Healthcare is a global specialist HIV company with a sustainable commitment to delivering advanced treatment and care, and improving access to medicines for people living with HIV worldwide.

ViiV Healthcare supports the Canadian HIV community through a number of different initiatives.

Visit to find out more.

Source: The Public Health Agency of Canada. Summary: Measuring Canada's Progress on the 90-90-90 HIV Targets.